REVB

REVELATION BIOSCIENCES, INC.

Healthcare · Biotechnology

$330.66 sample

+5.62 (+1.73%) 1D

Market cap

$1.66T

Price as of

2026-10-03

Latest filing

8-K · 2026-08-24

Alerts

8

Price$330.66 +19.72% 3M daily closessample

330.66272.68

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 25INSInsider sell: General Counsel
Sep 22INSInsider sell: Chief Executive Officer
Sep 16INSInsider buy: EVP, Operations
Sep 07INSInsider sell: 10% owner
Aug 27INSInsider sell: Director
Aug 24SEC10-Q filed
Aug 17INSInsider sell: Chief Executive Officer
Aug 07INSInsider sell: General Counsel

Sign up to see the real REVB record →

Company facts

SEC EDGAR registration

Name: REVELATION BIOSCIENCES, INC.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -23sample, -100 to +100
Reporting currency: USD

Who is positioning in REVB

sample

Insiders: 29 insider transactions over 90 days, net selling, $648.0M
Congress: 3 members traded over 90 days
Institutions · 13F: 29 funds hold $27.8B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$46.1B +11.9% y/y

Q4 2024Q3 2026

Inventory$27.9B +13.9% y/y

Q4 2024Q3 2026

Accounts receivable$21.1B +13.0% y/y

Q4 2024Q3 2026

Total debt$54.5B +14.7% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $1.21T +14.0% 3M
Sample peer B: $1.22T -4.3% 3M
Sample peer C: $546.4B -8.1% 3M
Sample peer D: $1.35T +2.5% 3M
Sample peer E: $570.1B -6.7% 3M